{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:59:49Z","timestamp":1792425589480,"version":"4.5.0"},"reference-count":131,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Thyroid cancer, a prevalent endocrine malignancy, is influenced by its tumor microenvironment (TME), with cancer-associated fibroblasts (CAFs) playing a pivotal role in disease progression. Molecularly, CAFs orchestrate a pro-tumorigenic niche via cytokine secretion and extracellular matrix (ECM) stiffening, underscoring their targetability. Therapeutic strategies, including small molecule inhibitor-based therapies, immune-based therapies, nanoparticle-based approaches, and combination regimens, have been evaluated for their efficacy in disrupting CAF functionality. CAFs from resident fibroblasts or recruited precursors can promote the progression of thyroid cancer through ECM remodeling, angiogenesis, and epithelial\u2013mesenchymal transition (EMT) induction while facilitating immune evasion. These processes can enhance tumor invasiveness, metastasis, and resistance to conventional therapies. Preclinical studies using thyroid cancer models have demonstrated promising outcomes, such as reduced tumor burden and enhanced drug sensitivity upon CAF inhibition. Emerging clinical trials have tested CAF-directed agents in patient cohorts and validated these findings. However, many challenges persist, including the identification of reliable CAF-specific biomarkers, optimization of treatment timing, and integration of the biomarkers into personalized medicine frameworks. This review explores the therapeutic potential of CAFs for thyroid cancers, emphasizing their origin, activation, and multifaceted contributions to tumor growth. This review synthesizes current evidence, highlighting CAFs as a novel therapeutic frontier for thyroid cancers. Future research should focus on refined biomarker discovery and strategic therapeutic sequencing to maximize clinical benefits, providing a roadmap for translating CAF-targeted approaches into effective treatments for thyroid cancers.<\/jats:p>","DOI":"10.1097\/js9.0000000000003352","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:04:55Z","timestamp":1757336695000},"page":"1448-1464","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Cancer-associated fibroblasts as a potential therapeutic target for thyroid cancers"],"prefix":"10.1097","volume":"112","author":[{"given":"Kashmira","family":"Chakraborty","sequence":"first","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Indian Institute of Technology (Indian School of Mines), Dhanbad, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya Lakshmi","family":"Rajendran","sequence":"additional","affiliation":[{"name":"BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu, Republic of Korea"},{"name":"Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea"},{"name":"Cardiovascular Research Institute, Kyungpook National University, Daegu, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shristy","family":"Kothiwal","sequence":"additional","affiliation":[{"name":"Infection Biology Group, CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Majhi","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, North Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuvab","family":"Dey","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, North Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhrojyoti","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Madras, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrajeet","family":"Dhara","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Jaypee Institute of Information Technology Noida, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijula","family":"Batabyal","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Medical engineering , National Institute of Technology , Rourkela, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreyee","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Medical engineering , National Institute of Technology , Rourkela, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Moon","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea"},{"name":"Cardiovascular Research Institute, Kyungpook National University, Daegu, Republic of Korea"},{"name":"Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-4604","authenticated-orcid":false,"given":"Prakash","family":"Gangadaran","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea"},{"name":"Cardiovascular Research Institute, Kyungpook National University, Daegu, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Cheol","family":"Ahn","sequence":"additional","affiliation":[{"name":"BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu, Republic of Korea"},{"name":"Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea"},{"name":"Cardiovascular Research Institute, Kyungpook National University, Daegu, Republic of Korea"},{"name":"Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,6]]},"reference":[{"key":"R1-20260518","doi-asserted-by":"crossref","first-page":"1284\u201397","DOI":"10.1158\/1055-9965.EPI-21-1440","article-title":"Epidemiology of thyroid cancer","volume":"31","author":"Kitahara","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R2-20260518","doi-asserted-by":"crossref","first-page":"17\u201329","DOI":"10.1038\/s41574-019-0263-x","article-title":"Geographic influences in the global rise of thyroid cancer","volume":"16","author":"Kim","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R3-20260518","doi-asserted-by":"crossref","first-page":"1875\u201386","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R5-20260518","first-page":"66\u201372","article-title":"Risk factors for thyroid cancer: what do we know so far?","volume":"59","author":"Bogovi\u0107 Crn\u010di\u0107","year":"2020","journal-title":"Acta Clin Croat"},{"key":"R6-20260518","doi-asserted-by":"crossref","first-page":"1771\u201379","DOI":"10.2217\/fon.10.127","article-title":"Thyroid cancer gender disparity","volume":"6","author":"Rahbari","year":"2010","journal-title":"Future Oncol"},{"key":"R7-20260518","doi-asserted-by":"crossref","first-page":"646\u201374","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"R8-20260518","doi-asserted-by":"crossref","first-page":"5591\u201396","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J Cell Sci"},{"key":"R9-20260518","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.3390\/ijms20184413","article-title":"Immune and inflammatory cells in thyroid cancer microenvironment","volume":"20","author":"Ferrari","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R11-20260518","doi-asserted-by":"crossref","first-page":"205\u201317","DOI":"10.1007\/s12672-020-00390-6","article-title":"The thyroid tumor microenvironment: potential targets for therapeutic intervention and prognostication","volume":"11","author":"MacDonald","year":"2020","journal-title":"Horm Cancer"},{"key":"R12-20260518","first-page":"253\u201369","article-title":"Tumor microenvironment-associated pericyte populations may impact therapeutic response in thyroid cancer","volume":"1329","author":"Iesato","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"R13-20260518","doi-asserted-by":"crossref","first-page":"1503\u201323","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"\u00d6hlund","year":"2014","journal-title":"J Exp Med"},{"key":"R14-20260518","doi-asserted-by":"crossref","first-page":"5138\u201353","DOI":"10.1158\/1078-0432.CCR-24-1004","article-title":"TAK1 promotes an immunosuppressive tumor microenvironment through cancer-associated fibroblast phenotypic conversion in pancreatic ductal adenocarcinoma","volume":"30","author":"Sheng","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R15-20260518","doi-asserted-by":"crossref","first-page":"4628\u201346","DOI":"10.1111\/bph.16505","article-title":"Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer","volume":"181","author":"Ruixin","year":"2024","journal-title":"Br J Pharmacol"},{"key":"R16-20260518","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3390\/cancers14061519","article-title":"B\u00eate noire of chemotherapy and targeted therapy: CAF-mediated resistance","volume":"14","author":"De","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R17-20260518","first-page":"967","article-title":"Unveiling the tumor microenvironment through fibroblast activation protein targeting in diagnostic nuclear medicine: a didactic review on biological rationales and key imaging agents","volume":"13","author":"Fouillet","year":"2024","journal-title":"Biology (Basel)"},{"key":"R18-20260518","doi-asserted-by":"crossref","first-page":"eado2402","DOI":"10.1126\/scitranslmed.ado2402","article-title":"Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy","volume":"16","author":"Liu","year":"2024","journal-title":"Sci Transl Med"},{"key":"R19-20260518","doi-asserted-by":"crossref","first-page":"9121\u201343","DOI":"10.2147\/IJN.S464788","article-title":"Development of dual diagnostic-therapeutic nanoformulation effective against pancreatic cancer in animal model","volume":"19","author":"Huang","year":"2024","journal-title":"Int J Nanomed"},{"key":"R21-20260518","doi-asserted-by":"crossref","first-page":"155984","DOI":"10.1016\/j.phymed.2024.155984","article-title":"Eupafolin hinders cross-talk between gastric cancer cells and cancer-associated fibroblasts by abrogating the IL18\/IL18RAP signaling axis","volume":"134","author":"Yan","year":"2024","journal-title":"Phytomedicine"},{"key":"R22-20260518","doi-asserted-by":"crossref","DOI":"10.2174\/0113862073366593250109093910","article-title":"Angelicin inhibits NSCLC tumor growth via the inhibition of cancer-associated fibroblasts","author":"Ding","year":"2025","journal-title":"Comb Chem High Throughput Screen"},{"key":"R23-20260518","article-title":"234\u2005Breaking barriers in solid tumors with SMART allogeneic CAR T-cells","volume":"12","author":"Erler","year":"2024","journal-title":"J Iimmunother Cancer"},{"key":"R24-20260518","doi-asserted-by":"crossref","first-page":"2326s","DOI":"10.1158\/1078-0432.CCR-05-2517","article-title":"Identifying and overcoming immune resistance mechanisms in the melanoma tumor microenvironment","volume":"12","author":"Gajewski","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R25-20260518","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.3390\/biomedicines10112988","article-title":"Cancer metastasis and treatment resistance: mechanistic insights and therapeutic targeting of cancer stem cells and the tumor microenvironment","volume":"10","author":"Kilmister","year":"2022","journal-title":"Biomedicines"},{"key":"R26-20260518","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","article-title":"New horizons in tumor microenvironment biology: challenges and opportunities","volume":"13","author":"Chen","year":"2015","journal-title":"BMC Med"},{"key":"R27-20260518","doi-asserted-by":"crossref","first-page":"2346\u201351","DOI":"10.1073\/pnas.0508139103","article-title":"Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation","volume":"103","author":"Majdalawieh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-20260518","first-page":"482\u201397","article-title":"Cancer associated fibroblasts: the dark side of the coin","volume":"1","author":"Cirri","year":"2011","journal-title":"Am J Cancer Res"},{"key":"R29-20260518","doi-asserted-by":"crossref","first-page":"582\u201398","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"R30-20260518","doi-asserted-by":"crossref","first-page":"174\u201386","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"R31-20260518","doi-asserted-by":"crossref","first-page":"222\u201332","DOI":"10.1016\/j.canlet.2021.08.002","article-title":"The transformation of cancer-associated fibroblasts: current perspectives on the role of TGF-\u03b2 in CAF mediated tumor progression and therapeutic resistance","volume":"520","author":"Chandra Jena","year":"2021","journal-title":"Cancer Lett"},{"key":"R32-20260518","doi-asserted-by":"crossref","first-page":"4821\u201333","DOI":"10.1038\/onc.2014.410","article-title":"Osteopontin mediates an MZF1-TGF-\u03b21-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer","volume":"34","author":"Weber","year":"2015","journal-title":"Oncogene"},{"key":"R33-20260518","first-page":"gutjnl\u20132024\u2013333638","article-title":"Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling","author":"Sun","year":"2025","journal-title":"Gut"},{"key":"R34-20260518","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1038\/s41598-019-44361-6","article-title":"Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression","volume":"9","author":"Fozzatti","year":"2019","journal-title":"Sci Rep"},{"key":"R35-20260518","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","article-title":"Stromal cells in the tumor microenvironment: accomplices of tumor progression?","volume":"14","author":"Zhao","year":"2023","journal-title":"Cell Death Dis"},{"key":"R36-20260518","doi-asserted-by":"crossref","first-page":"673\u201380","DOI":"10.3803\/EnM.2020.401","article-title":"Tumor cells and cancer-associated fibroblasts: a synergistic crosstalk to promote thyroid cancer","volume":"35","author":"Fozzatti","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R38-20260518","first-page":"550\u201355","article-title":"Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma","volume":"61","author":"L\u00f6hr","year":"2001","journal-title":"Cancer Res"},{"key":"R39-20260518","doi-asserted-by":"crossref","first-page":"1316\u201326","DOI":"10.1038\/sj.bjc.6602141","article-title":"Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer","volume":"91","author":"Aoyagi","year":"2004","journal-title":"Br J Cancer"},{"key":"R40-20260518","doi-asserted-by":"crossref","first-page":"135\u201347","DOI":"10.1016\/j.ccr.2009.12.041","article-title":"Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"key":"R41-20260518","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/cancers15102863","article-title":"Crosstalk between thyroid carcinoma and tumor-correlated immune cells in the tumor microenvironment","volume":"15","author":"Song","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R42-20260518","doi-asserted-by":"crossref","first-page":"735\u201342","DOI":"10.1089\/thy.2009.0017","article-title":"Fibroblast-mediated in vivo and in vitro growth promotion of tumorigenic rat thyroid carcinoma cells but not normal Fisher rat thyroid follicular cells","volume":"19","author":"Saitoh","year":"2009","journal-title":"Thyroid"},{"key":"R43-20260518","doi-asserted-by":"crossref","first-page":"4496\u2013510","DOI":"10.18632\/oncotarget.23388","article-title":"A dual mechanism of activation of the Sonic Hedgehog pathway in anaplastic thyroid cancer: crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma","volume":"9","author":"Parascandolo","year":"2018","journal-title":"Oncotarget"},{"key":"R44-20260518","doi-asserted-by":"crossref","first-page":"1205\u201317","DOI":"10.2147\/OTT.S294725","article-title":"Cancer-associated fibroblasts positively correlate with dedifferentiation and aggressiveness of thyroid cancer","volume":"14","author":"Wen","year":"2021","journal-title":"Onco Targets Ther"},{"key":"R45-20260518","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/cancers12010112","article-title":"Cancer associated fibroblasts and senescent thyroid cells in the invasive front of thyroid carcinoma","volume":"12","author":"Minna","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R46-20260518","doi-asserted-by":"crossref","first-page":"367\u201377","DOI":"10.1158\/0008-5472.CAN-14-2304","article-title":"miR30a inhibits LOX expression and anaplastic thyroid cancer progression","volume":"75","author":"Boufraqech","year":"2015","journal-title":"Cancer Res"},{"key":"R47-20260518","doi-asserted-by":"crossref","first-page":"79\u201392","DOI":"10.1089\/thy.2018.0424","article-title":"Lysyl oxidase is a key player in BRAF\/MAPK pathway-driven thyroid cancer aggressiveness","volume":"29","author":"Boufraqech","year":"2019","journal-title":"Thyroid"},{"key":"R48-20260518","doi-asserted-by":"crossref","first-page":"147\u201376","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol Rev"},{"key":"R49-20260518","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"R50-20260518","doi-asserted-by":"crossref","first-page":"866\u201382","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"R51-20260518","doi-asserted-by":"crossref","first-page":"159\u201377","DOI":"10.1007\/s10456-019-09688-8","article-title":"Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer","volume":"23","author":"Unterleuthner","year":"2020","journal-title":"Angiogenesis"},{"key":"R52-20260518","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10+GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"R53-20260518","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41419-020-03294-z","article-title":"A new risk factor indicator for papillary thyroid cancer based on immune infiltration","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis"},{"key":"R55-20260518","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s11658-022-00351-7","article-title":"Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer","volume":"27","author":"Muchli\u0144ska","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"R56-20260518","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R58-20260518","doi-asserted-by":"crossref","first-page":"436\u201344","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"R59-20260518","doi-asserted-by":"crossref","first-page":"6425\u201340","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"key":"R60-20260518","doi-asserted-by":"crossref","first-page":"155\u201361","DOI":"10.1111\/j.1600-065X.2008.00607.x","article-title":"The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance","volume":"222","author":"Allavena","year":"2008","journal-title":"Immunol Rev"},{"key":"R61-20260518","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/ijo.2021.5239","article-title":"Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway","volume":"59","author":"Chen","year":"2021","journal-title":"Int J Oncol"},{"key":"R62-20260518","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/cancers11040564","article-title":"Tumor-associated neutrophils in cancer: going pro","volume":"11","author":"Wu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R63-20260518","doi-asserted-by":"crossref","first-page":"1717\u201335","DOI":"10.1002\/hep.31792","article-title":"Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression","volume":"73","author":"Song","year":"2021","journal-title":"Hepatology"},{"key":"R64-20260518","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41419-018-0458-4","article-title":"Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma","volume":"9","author":"Cheng","year":"2018","journal-title":"Cell Death Dis"},{"key":"R65-20260518","doi-asserted-by":"crossref","first-page":"28\u201335","DOI":"10.1016\/j.imlet.2019.03.011","article-title":"Mast cells: a double-edged sword in cancer","volume":"209","author":"Derakhshani","year":"2019","journal-title":"Immunol Lett"},{"key":"R66-20260518","doi-asserted-by":"crossref","first-page":"1031\u201341","DOI":"10.2353\/ajpath.2010.100070","article-title":"Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy","volume":"177","author":"Johansson","year":"2010","journal-title":"Am J Pathol"},{"key":"R67-20260518","doi-asserted-by":"crossref","first-page":"479\u201385","DOI":"10.1097\/CMR.0000000000000192","article-title":"Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma","volume":"25","author":"Siiskonen","year":"2015","journal-title":"Melanoma Res"},{"key":"R68-20260518","first-page":"270\u201388","article-title":"Mast cells, angiogenesis and cancer","volume":"716","author":"Ribatti","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"R69-20260518","first-page":"19\u201326","article-title":"Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation","volume":"1796","author":"Maltby","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"R70-20260518","doi-asserted-by":"crossref","first-page":"1025\u201336","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat Immunol"},{"key":"R71-20260518","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front Immunol"},{"key":"R72-20260518","first-page":"671\u201388","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"R73-20260518","doi-asserted-by":"crossref","first-page":"430\u201341","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"R74-20260518","doi-asserted-by":"crossref","first-page":"3784\u201392","DOI":"10.4049\/jimmunol.181.6.3784","article-title":"TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells","volume":"181","author":"Trotta","year":"2008","journal-title":"J Immunol"},{"key":"R75-20260518","doi-asserted-by":"crossref","first-page":"6248590","DOI":"10.1155\/2018\/6248590","article-title":"Altered NKp30, NKp46, NKG2D, and DNAM-1 expression on circulating NK cells is associated with tumor progression in human gastric cancer","volume":"2018","author":"Han","year":"2018","journal-title":"J Immunol Res"},{"key":"R76-20260518","doi-asserted-by":"crossref","first-page":"1297\u2013304","DOI":"10.3892\/ijo.2016.3631","article-title":"Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR\/CD155), a ligand of activating NK receptor","volume":"49","author":"Inoue","year":"2016","journal-title":"Int J Oncol"},{"key":"R77-20260518","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40364-025-00735-9","article-title":"Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics","volume":"13","author":"Gangadaran","year":"2025","journal-title":"Biomark Res"},{"key":"R78-20260518","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1038\/oncsis.2016.7","article-title":"Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation","volume":"5","author":"Cheng","year":"2016","journal-title":"Oncogenesis"},{"key":"R79-20260518","doi-asserted-by":"crossref","first-page":"202\u201313","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"R80-20260518","doi-asserted-by":"crossref","first-page":"109\u201318","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res"},{"key":"R81-20260518","doi-asserted-by":"crossref","first-page":"3895\u2013917","DOI":"10.1007\/s00262-023-03549-6","article-title":"Tumor-associated macrophages as a potential therapeutic target in thyroid cancers","volume":"72","author":"Zhu","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"R82-20260518","doi-asserted-by":"crossref","first-page":"8509\u201321","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J Cell Physiol"},{"key":"R83-20260518","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3389\/fimmu.2019.01906","article-title":"CD8+ T lymphocyte and NK cell network: circuitry in the cytotoxic domain of immunity","volume":"10","author":"Uzhachenko","year":"2019","journal-title":"Front Immunol"},{"key":"R84-20260518","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/cells14060403","article-title":"Cross-talk between cancer and its cellular environment-a role in cancer progression","volume":"14","author":"Turlej","year":"2025","journal-title":"Cells"},{"key":"R85-20260518","doi-asserted-by":"crossref","first-page":"3\u20138","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"R86-20260518","doi-asserted-by":"crossref","first-page":"739\u201352","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"R87-20260518","doi-asserted-by":"crossref","first-page":"3365\u201376","DOI":"10.1172\/JCI80006","article-title":"Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages","volume":"125","author":"Ugel","year":"2015","journal-title":"J Clin Invest"},{"key":"R88-20260518","doi-asserted-by":"crossref","first-page":"547\u201362","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"R89-20260518","doi-asserted-by":"crossref","first-page":"5329\u201340","DOI":"10.1158\/1078-0432.CCR-12-1632","article-title":"Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma","volume":"18","author":"Khalili","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R90-20260518","doi-asserted-by":"crossref","first-page":"5552\u201362","DOI":"10.4049\/jimmunol.178.9.5552","article-title":"Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells","volume":"178","author":"Nazareth","year":"2007","journal-title":"J Immunol"},{"key":"R92-20260518","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12964-023-01125-0","article-title":"What is new in cancer-associated fibroblast biomarkers?","volume":"21","author":"Zhao","year":"2023","journal-title":"Cell Commun Signal"},{"key":"R94-20260518","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.3390\/cancers13184720","article-title":"The role of cancer-associated fibroblasts in cancer invasion and metastasis","volume":"13","author":"Asif","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R95-20260518","doi-asserted-by":"crossref","first-page":"1089068","DOI":"10.3389\/fcell.2023.1089068","article-title":"Cancer-associated fibroblasts: the chief architect in the tumor microenvironment","volume":"11","author":"Sarkar","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"R96-20260518","doi-asserted-by":"crossref","first-page":"1340124","DOI":"10.3389\/fmolb.2024.1340124","article-title":"Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer","volume":"11","author":"Ozmen","year":"2024","journal-title":"Front Mol Biosci"},{"key":"R97-20260518","doi-asserted-by":"crossref","first-page":"1019072","DOI":"10.3389\/fendo.2022.1019072","article-title":"Integrated analysis of fibroblasts molecular features in papillary thyroid cancer combining single-cell and bulk RNA sequencing technology","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R98-20260518","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1038\/s41598-023-36092-6","article-title":"Cancer-associated fibroblast-derived exosome microRNA-21 promotes angiogenesis in multiple myeloma","volume":"13","author":"Miaomiao","year":"2023","journal-title":"Sci Rep"},{"key":"R99-20260518","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.3390\/cancers14174172","article-title":"Thyroid cancer and fibroblasts","volume":"14","author":"Avagliano","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R100-20260518","doi-asserted-by":"crossref","first-page":"147\u201355","DOI":"10.1016\/j.canlet.2018.06.038","article-title":"IL6\/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells","volume":"433","author":"Notarangelo","year":"2018","journal-title":"Cancer Lett"},{"key":"R101-20260518","doi-asserted-by":"crossref","first-page":"435\u201355","DOI":"10.1007\/s12020-019-02030-8","article-title":"Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review","volume":"66","author":"Shakib","year":"2019","journal-title":"Endocrine"},{"key":"R103-20260518","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12943-024-02106-8","article-title":"Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"R105-20260518","doi-asserted-by":"crossref","first-page":"567\u201381","DOI":"10.1016\/j.actbio.2021.09.003","article-title":"Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis","volume":"135","author":"Hu","year":"2021","journal-title":"Acta Biomater"},{"key":"R106-20260518","doi-asserted-by":"crossref","first-page":"1010428317712592","DOI":"10.1177\/1010428317712592","article-title":"Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1\/FGFR4 signaling","volume":"39","author":"Sun","year":"2017","journal-title":"Tumour Biol"},{"key":"R107-20260518","doi-asserted-by":"crossref","first-page":"2641\u201353","DOI":"10.1002\/cam4.1517","article-title":"Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models","volume":"7","author":"Matsuki","year":"2018","journal-title":"Cancer Med"},{"key":"R108-20260518","doi-asserted-by":"crossref","first-page":"1285\u201386","DOI":"10.1016\/j.annonc.2020.07.007","article-title":"Inhibiting fibroblast growth factor receptors in cancer - the next generation","volume":"31","author":"Schuler","year":"2020","journal-title":"Ann Oncol"},{"key":"R109-20260518","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.3390\/ijms232012578","article-title":"Cell component and function of tumor microenvironment in thyroid cancer","volume":"23","author":"Shin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R110-20260518","doi-asserted-by":"crossref","first-page":"1195\u2013200","DOI":"10.1016\/j.bbrc.2020.06.043","article-title":"Membrane type 1 matrix metalloproteinase regulates anaplastic thyroid carcinoma cell growth and invasion into the collagen matrix","volume":"529","author":"Yoshida","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R111-20260518","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/cancers15010167","article-title":"The role of CXC chemokines in cancer progression","volume":"15","author":"Wu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R114-20260518","doi-asserted-by":"crossref","first-page":"988295","DOI":"10.3389\/fendo.2022.988295","article-title":"Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R115-20260518","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s12672-024-01677-8","article-title":"Nanomedicine mediated thyroid cancer diagnosis and treatment: an approach from generalized to personalized medicine","volume":"15","author":"Gulwani","year":"2024","journal-title":"Discov Oncol"},{"key":"R116-20260518","doi-asserted-by":"crossref","first-page":"e202400425","DOI":"10.1002\/chem.202400425","article-title":"Engineered nanomaterials for tumor immune microenvironment modulation in cancer immunotherapy","volume":"30","author":"Xing","year":"2024","journal-title":"Chemistry"},{"key":"R117-20260518","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.3390\/cancers13225613","article-title":"TGF\u03b21 Secreted by cancer-associated fibroblasts as an inductor of resistance to photodynamic therapy in squamous cell carcinoma cells","volume":"13","author":"Gallego-Rentero","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R118-20260518","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"key":"R119-20260518","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/pharmaceutics14051040","article-title":"The role of the kinase inhibitors in thyroid cancers","volume":"14","author":"Cuomo","year":"2022","journal-title":"Pharmaceutics"},{"key":"R120-20260518","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/cancers11091382","article-title":"Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies","volume":"11","author":"Aashiq","year":"2019","journal-title":"Cancers"},{"key":"R121-20260518","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/ERC-22-0006","article-title":"Advanced RAI-refractory thyroid cancer: an update on treatment perspectives","volume":"29","author":"Karapanou","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"R122-20260518","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.3390\/cancers14225487","article-title":"Effect of collagen matrix on doxorubicin distribution and cancer cells\u2019 response to treatment in 3D tumor model","volume":"14","author":"Druzhkova","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R123-20260518","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R125-20260518","doi-asserted-by":"crossref","first-page":"114500","DOI":"10.1016\/j.ejmech.2022.114500","article-title":"Targeted therapy and drug resistance in thyroid cancer","volume":"238","author":"Zhang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"R126-20260518","doi-asserted-by":"crossref","first-page":"134\u201342","DOI":"10.1111\/cas.12584","article-title":"Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine","volume":"106","author":"Ohshio","year":"2015","journal-title":"Cancer Sci"},{"key":"R127-20260518","doi-asserted-by":"crossref","first-page":"1913791","DOI":"10.1080\/19420862.2021.1913791","article-title":"Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy","volume":"13","author":"Waldhauer","year":"2021","journal-title":"MAbs"},{"key":"R128-20260518","first-page":"65\u201377","article-title":"Novel fibroblast activation protein inhibitor-based targeted theranostics for radioiodine-refractory differentiated thyroid cancer patients: a pilot study","volume":"32","author":"Ballal","year":"2022","journal-title":"Thyroid"},{"key":"R129-20260518","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3390\/cancers12113108","article-title":"Cancer-associated fibroblasts: understanding their heterogeneity","volume":"12","author":"Louault","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R130-20260518","doi-asserted-by":"crossref","first-page":"217452","DOI":"10.1016\/j.canlet.2025.217452","article-title":"Single-cell transcriptomics reveals intratumor heterogeneity and the potential roles of cancer stem cells and myCAFs in colorectal cancer liver metastasis and recurrence","volume":"612","author":"Zhan","year":"2025","journal-title":"Cancer Lett"},{"key":"R131-20260518","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","article-title":"Cancer associated fibroblasts in cancer development and therapy","volume":"18","author":"Jia","year":"2025","journal-title":"J Hematol Oncol"},{"key":"R132-20260518","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3390\/cancers15072014","article-title":"Fibroblasts as turned agents in cancer progression","volume":"15","author":"Wieder","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R133-20260518","doi-asserted-by":"crossref","first-page":"259\u201372","DOI":"10.1111\/imr.12978","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunol Rev"},{"key":"R134-20260518","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/cancers13143466","article-title":"Extracellular matrices and cancer-associated fibroblasts: targets for cancer diagnosis and therapy?","volume":"13","author":"Belhabib","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R135-20260518","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41419-020-2468-2","article-title":"Effect of naive and cancer-educated fibroblasts on colon cancer cell circadian growth rhythm","volume":"11","author":"Parascandolo","year":"2020","journal-title":"Cell Death Dis"},{"key":"R136-20260518","doi-asserted-by":"crossref","first-page":"e006130","DOI":"10.1136\/jitc-2022-006130","article-title":"Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6","volume":"11","author":"Lee","year":"2023","journal-title":"J Immunother Cancer"},{"key":"R137-20260518","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","article-title":"Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas","volume":"15","author":"Broz","year":"2024","journal-title":"Nat Commun"},{"key":"R138-20260518","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.3390\/molecules27217145","article-title":"Recent advances in exosomal miRNA biosensing for liquid biopsy","volume":"27","author":"Lin","year":"2022","journal-title":"Molecules"},{"key":"R139-20260518","doi-asserted-by":"crossref","first-page":"685396","DOI":"10.1155\/2014\/685396","article-title":"Anaplastic thyroid carcinoma: current treatments and potential new therapeutic options with emphasis on TfR1\/CD71","volume":"2014","author":"Parenti","year":"2014","journal-title":"Int J Endocrinol"},{"key":"R140-20260518","doi-asserted-by":"crossref","first-page":"1385\u201393","DOI":"10.1089\/thy.2014.0134","article-title":"BRAFV600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration","volume":"24","author":"Angell","year":"2014","journal-title":"Thyroid"},{"key":"R141-20260518","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12032-023-02260-x","article-title":"Exploring the advances of single-cell RNA sequencing in thyroid cancer: a narrative review","volume":"41","author":"Tan","year":"2023","journal-title":"Med Oncol"},{"key":"R142-20260518","article-title":"Overcoming cancer treatment resistance: unraveling the role of cancer-associated fibroblasts","author":"Wang","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"R143-20260518","doi-asserted-by":"crossref","first-page":"613\u201321","DOI":"10.1111\/cas.16443","article-title":"Targeting Cancer-Associated Fibroblasts: eliminate or Reprogram?","volume":"116","author":"Yamazaki","year":"2025","journal-title":"Cancer Sci"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:17:56Z","timestamp":1779110276000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003352","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,6]]},"assertion":[{"value":"2025-04-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}